Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.
about
Viral hemorrhagic fevers: advancing the level of treatmentOutbreaks of Ebola virus disease in Africa: the beginnings of a tragic sagaClinical management of filovirus-infected patientsThe 2014–2015 Ebola outbreak in West Africa: Hands OnPassive immunity in prevention and treatment of infectious diseasesSustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAbEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentDelayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaquesEbola haemorrhagic feverEbola virus disease and critical illness.Convalescent plasma: new evidence for an old therapeutic tool?Pre-symptomatic diagnosis and treatment of filovirus diseasesEbola Virus Disease: Focus on ChildrenMouse models for filovirus infectionsViral infections during pregnancyNeutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against itEbolavirus glycoprotein structure and mechanism of entryCell-targeting antibodies in immunity to EbolaBench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentationAntibodies for biodefensePreparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught UsProduction of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal CattleOffering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infectionsEbola Viral Disease in West Africa: A Threat to Global Health, Economy and Political StabilityEbola virus disease: What clinicians in the United States need to know.Progress towards the treatment of Ebola haemorrhagic fever.Insights from clinical research completed during the west Africa Ebola virus disease epidemic.The ongoing evolution of antibody-based treatments for Ebola virus infection.A review of treatment modalities for Middle East Respiratory Syndrome.Experimental Therapies for Ebola Virus Disease: What Have We Learned?Discovery of an antibody for pan-ebolavirus therapyClinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008Ebola virus can be effectively neutralized by antibody produced in natural human infection.Neutralizing antibody fails to impact the course of Ebola virus infection in monkeysEthics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic.Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.Forty years of the war against Ebola.Viral hemorrhagic fever hazards for travelers in Africa.Reversion of advanced Ebola virus disease in nonhuman primates with ZMappEbola virus disease: an update for anesthesiologists and intensivists.
P2860
Q21245298-BFE6F234-E725-4F9F-931A-3DA4EEEA34AAQ21245402-614A225B-27CC-4803-89E4-64E82F706746Q22305518-388FBAE3-4A0F-4A65-90BA-7ED0117849B5Q24049114-0ED64EF6-51A8-4457-9779-5A6DE7CEB171Q24550699-B14660F6-D873-4F17-8CA0-6A6C1EB6F508Q24594601-ED1BE2CA-0662-4186-BDB6-33DD2055F0C9Q24597625-C48C8AA3-3C8B-4371-8902-B398780BEC9FQ24612811-CF7CE879-F7AF-47A1-B4B7-4C2F7210018EQ24629338-15CA8A7E-1941-466E-B5F2-2665548F521BQ26250274-D748007F-C435-4B4C-A880-A0649988926CQ26775412-BCDDEBA6-6F46-4E77-B543-E6E186EFBE08Q26823831-8A664F31-0C0D-4FD9-9420-31C242F12553Q26824080-E86D0CAE-FE2E-40E1-BF62-7ADD8967A176Q27011569-A67B2CF5-0931-454F-894E-FF2C5BBCE4F5Q27027087-6C4DC0B5-88D3-4118-A503-4689857B1F90Q27489891-EB2CEAD6-74C6-4262-9138-05C5D9E1BAAFQ27490991-9B598D2A-41E0-430F-BC93-F81AB482C8AEQ28068972-35C20CD4-A65F-4BBF-8E94-0FC721CBD55CQ28386164-E8DE927A-3AA9-4A17-AE87-58C83F2DD2B9Q28394941-DFC1325F-5E45-44F5-A8AB-BBC81C099CEBQ28397866-4B47D86E-BB9D-4DF2-B195-4F4AEE707903Q28603849-D9536C98-7F11-4BEB-B5D4-91BCE983A808Q29994672-80AD2F66-46BB-44EF-82F1-C84F4C52A425Q30148821-DE69D646-6D7E-4BFA-B1ED-442F3DC13D61Q30203249-7AE2450E-8371-4692-A2C0-206DBDA3F959Q30230272-BEC506C9-0DBD-48EF-854B-50EE7A128788Q30234590-B7CB5363-FD2B-4E82-B223-45D1E7ECC529Q30235022-80BBB41E-18DC-4E09-BCE4-5F9F4CC0CAADQ30248209-FD91DAD9-0701-4DFF-8885-C7917A045EC0Q30275032-88C38A71-0622-4739-B9B0-7A3DD19218AFQ30385927-D10325C3-07BA-44B4-85D3-D40BF89F5609Q30584295-1BA3E8AE-8249-45B7-BDFF-F5BAF9FD23A2Q30712477-C051B1AC-71B1-42D0-A54A-14A4D5D490F1Q33269796-EA8C636A-0001-4E72-9C97-A846984806FFQ33837161-997CD674-D038-44B8-A49A-32ACF7E56117Q33840716-795187F8-0880-4BD2-A4C9-DF3358BEF240Q34173952-C10418AC-CC48-41C8-A248-EFD4F5AD22E9Q34398543-14042CBD-80B9-45F5-9C24-819DF2FF4393Q34426585-0AEE3B94-F24C-45D2-89E6-08204C7A40EDQ34446478-AB162C64-C19F-462D-9442-06D2AD66D1CA
P2860
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@ast
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@en
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@nl
type
label
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@ast
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@en
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@nl
prefLabel
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@ast
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@en
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@nl
P2093
P921
P356
P1476
Treatment of Ebola hemorrhagic ...... tific and Technical Committee.
@en
P2093
Colebunders R
Massamba M
P304
P356
10.1086/514298
P407
P478
179 Suppl 1
P577
1999-02-01T00:00:00Z